ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Scientist I, Computational Biology at CRISPR Therapeutics - ApplyBlast

Scientist I, Computational Biology

CRISPR Therapeutics

1 day ago

3.1 on Glassdoor

South Boston, Massachusetts, United States

Hybrid

Full Time

Junior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Computational Biology Scientist will apply computational genomics to advance next-generation gene editing therapies toward the clinic, characterizing gene-editing safety and tackling complex bioinformatics challenges. The role involves developing and maintaining computational infrastructure, analysis platforms, and internal web applications to support research and drug development. The successful candidate will collaborate with cross-functional research groups to drive therapeutic programs forward.

Responsibilities

Lead computational biology and genomics activities in drug development
Develop and implement novel computational pipelines for genomic data analysis
Characterize off-target gene editing to ensure therapeutic safety

Skills

Qualifications

Ph.D. in computational biology, bioinformatics, genomics, computer science, or a related fieldM.S. with an exceptional track record and eight or more years of relevant experience

About CRISPR Therapeutics

crisprtx.com

Headquarters

Boston, Massachusetts, United States

Company Size

201-500 employees

Founded

2013

View Profile

CRISPR Therapeutics is a gene-editing company pioneering the development of transformative medicines using CRISPR/Cas9 technology to treat serious diseases. The company has a broad pipeline spanning hemoglobinopathies, immuno-oncology, autoimmune diseases, in vivo editing, and regenerative medicine, including CASGEVY™, the first-ever approved CRISPR-based therapy for sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics operates across multiple clinical and preclinical programs in collaboration with partners such as Vertex Pharmaceuticals.